Symptom prevalence and burden, and the risk of depression among patients with advanced cancer attending two South African oncology units

• Published in: Ecancermedicalscience 2022-01, Vol.16, p.1349-1349
• Main Authors: Farrant, Lindsay, Harding, Richard, Anderson, David, Greeff, Linda, Kassanjee, Reshma, Krause, R, Mohamed, Zainab, Parkes, Jeannette, Gwyther, Liz
• Format: Article
• Language: English
• ISSN: 1754-6605; 1754-6605
• DOI: 10.3332/ecancer.2022.1349

The incidence of cancer is predicted to increase globally by 47% between 2020 and 2040, largely in low and middle-income countries. The World Health Organisation and World Health Assembly recognise palliative care as an essential component of cancer care. The evidence of palliative care needs among South African oncology patients is sparse. This study aimed to describe the prevalence and burden of symptoms and the risk of depression amongst oncology patients with stage 3 or 4 cancer. Demographic and clinical data were collected and the Memorial Symptom Assessment Scale Short Form was used to measure the 7-day period prevalence of 28 physical and 4 psychological symptoms of patients receiving oncology care. The Centre for Epidemiological Studies Depression Scale was used to measure the risk of depression. A total of = 343 patients were recruited, of which = 229 (66.8%) had stage 4 cancer. The mean number of symptoms was 11.56 (SD = 5.86). Pain and feeling drowsy/tired were the two most prevalent symptoms. = 66 (19.3%) were at risk of mild depression and = 27 (7.9%) for major depression. Pain and depression persist in advanced cancer care despite the advances in policy and clinical education. Health services research must now focus on how to enact this in routine practice.